FAB22 Mar 2024 20:20
FAB placing, 14th Feb, £1.3m, 34,375,000 new ordinary shares of 4p 6% discount...
MC £3,7m
Shares in issue 95.37M
52 week high 50.0p( did a Lorna, 84% discount 5p, May '23)
52 week low 3.1p
Plenty sounds pie in the sky, what does Pharma Swissy think ?
Is this an official validation route, like the FDA ?
The Company's prospects have been improved further by the entry into of an agreement with the National Cancer Institute ("NCI"), part of the National Institutes of Health (NIH) in the USA, to "validate" the OptiMAL® platform, as announced on 28th November 2023. The NCI is a highly prestigious organisation and recognises the potential value OptiMAL®.........
https://www.lse.co.uk/rns/FAB/placing-to-raise-1941631375000-z0n8w95vavaohhz.html
=========================
MC 26,014,946 @ 50p £13m
=====================
33,438,768 May Placing(84% discount)
After May Placing
59,453,714 @5p £3.2m
Spikes to 7p, MC £4.2m